Tracey Sacco
Corporate Officer/Principal at SCHOLAR ROCK HOLDING CORPORATION
Net worth: 875 302 $ as of 31/03/2024
Profile
Tracey Sacco is currently the Chief Commercial Officer at Scholar Rock Holding Corp.
Prior to this, she worked at Acceleron Pharma, Inc. as the SVP-Global Marketing & Alliance Management from 2012 to 2021.
She received her undergraduate degree from Boston College and her MBA from The Leonard N Stern School of Business.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 12/02/2024 | 49,285 ( 0.06% ) | 875 302 $ | 31/03/2024 |
Tracey Sacco active positions
| Companies | Position | Start |
|---|---|---|
| SCHOLAR ROCK HOLDING CORPORATION | Corporate Officer/Principal | 06/02/2023 |
Former positions of Tracey Sacco
| Companies | Position | End |
|---|---|---|
| ACCELERON PHARMA INC. | Sales & Marketing | 01/09/2021 |
Training of Tracey Sacco
| Boston College | Undergraduate Degree |
| The Leonard N Stern School of Business | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| SCHOLAR ROCK HOLDING CORPORATION | Health Technology |
| Private companies | 1 |
|---|---|
Acceleron Pharma, Inc.
 Acceleron Pharma, Inc. BiotechnologyHealth Technology Acceleron Pharma, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of therapeutics to treat serious and rare diseases. Its product candidates include Luspatercept, designed to patients with chronic anemia associated within a wide range of blood diseases; ACE-083, designed for the treatment of focal muscle disorders; and Sotatercept, designed to treat pulmonary arterial hypertension. The company was founded by John L. Knopf and Thomas P. Maniatis in June 2003 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Tracey Sacco